Risk of myocardial infarction and stroke after breast cancer: an analysis of a population of 1.3 million women from North-West Italy
The results supported the hypothesis about the toxic effect of BC therapies, suggesting that clinicians should routinely and actively screen for treatment-related toxicities in women with BC and that researchers should prioritize personalized treatments to minimize potentially devastating side effects.
Authors
- Alessandra Macciotta (ORCID: https://orcid.org/0000-0002-0287-7979)
- Sara Calabrese (ORCID: https://orcid.org/0000-0001-9066-0704)
- Pierfrancesco Franco (ORCID: https://orcid.org/0000-0003-2276-0687)
- Alberto Catalano (ORCID: https://orcid.org/0000-0003-2597-2060)
- Elisa Ferracin
- Fulvio Ricceri
- Gregory Winston Gilcrease
- Daniela Di Cuonzo
- Lucia Dansero (ORCID: https://orcid.org/0000-0003-2304-5378)
- Enrica Favaro (ORCID: https://orcid.org/0000-0001-5808-0224)
- Angelo d’Errico (ORCID: https://orcid.org/0000-0003-3171-413X)
- Gianmauro Numico
- Roberto Gnavi
- Eva Pagano
- Giuseppe Costa
Institutions
- Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT)
- Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT)
- Regional Health (US)
- Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo (IT)
- Piedmont Reference Center for Epidemiology and Cancer Prevention (IT)
- Department of Public Health (US)
- Piedmont University (US)
- Novamont (Italy) (IT)
- University of Turin (IT)
Publication Details
- Journal
- Breast Cancer Research and Treatment
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1007/s10549-026-07900-0
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00